BELOIT, Wisconsin, January 31, 2012 /PRNewswire/ --

Kerry Ingredients & Flavours is expanding its customer center of excellence in Beloit, Wisconsin, to include a new Cell Science laboratory. Building on the success of its companion site in Almere, The Netherlands, the new Cell Science laboratory will incorporate state-of-the-art technologies and media supplementation expertise to engage globally with Kerry's bio-pharma customers and technology partners.

"The new Cell Science laboratory expands our Media Enhancement Services capabilities for Cell Culture, Vaccines, Microbial Fermentation, and Diagnostics. Additionally, this new research and applications center with leading R&D expertise will advance our ability to customize cell media supplements to meet the evolving needs of the bio-pharma market globally," stated Christopher Wilcox, Kerry's Director of R&D overseeing Cell Culture & Media Supplementation technologies.

Kerry is investing more than $10 million in the expansion of the Cell Science laboratory and Kerry customer center of excellence, which includes a consumer nutrition center, extensive flavor labs and product ideation and customer collaboration suites.

"Expanding our Cell Science laboratory in the Kerry center allows us to advance our media ingredients and supplements portfolio while capturing greater synergies with Kerry's extensive analytical, research, development and applications expertise," stated Edmond Scanlon, President of Kerry's pharma and bio-pharma ingredients business. "This ultimately helps us deliver greater innovation and overall value for customers."

The expansion is expected to be complete by August 2012 and will add nearly 50 new jobs and an additional 30,000 square feet to the existing 260,000 square foot facility.

About Kerry Ingredients & Flavours
A division of Kerry Group, Kerry Ingredients & Flavours develops, manufactures and delivers innovative taste systems, functional ingredients and integrated solutions for the global food, beverage and pharmaceutical markets.

Serving the global pharmaceutical and bio-pharma markets under the trade name Sheffield Bio-Science, Kerry provides bio-pharma customers with a renowned product portfolio of media supplements including the industry-preferred HyPeps, Hy-Soy, NZ Amines, Primatones and Hy-Yests; as well as innovative new products such as Sheffield rInsulin ACF, Sheff-CHO ACF, Sheff-Vax ACF and Hy-Express systems.

Additionally, Kerry offers the pharmaceutical and nutrition markets a high quality excipient product line. including pharma-grade lactose, tablet coatings and pharma flavors, as well as custom developed innovative ingredient solutions to help customers succeed in the ever changing global marketplace.

http://www.kerry.com 

SOURCE Kerry Inc.